<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37296572</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>23</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Synchrotron-Based Fourier-Transform Infrared Micro-Spectroscopy of Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients Reveals a Unique Biomolecular Profile.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1451</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12111451</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, with the most common adult-onset neurodegenerative disorder affecting motoneurons. Although disruptions in macromolecular conformation and homeostasis have been described in association with ALS, the underlying pathological mechanisms are still not completely understood, and unambiguous biomarkers are lacking. Fourier Transform Infrared Spectroscopy (FTIR) of cerebrospinal fluid (CSF) is appealing to extensive interest due to its potential to resolve biomolecular conformation and content, as this approach offers a non-invasive, label-free identification of specific biologically relevant molecules in a few microliters of CSF sample. Here, we analyzed the CSF of 33 ALS patients compared to 32 matched controls using FTIR spectroscopy and multivariate analysis and demonstrated major differences in the molecular contents. A significant change in the conformation and concentration of RNA is demonstrated. Moreover, significantly increased glutamate and carbohydrates are found in ALS. Moreover, key markers of lipid metabolism are strongly altered; specifically, we find a decrease in unsaturated lipids and an increase in peroxidation of lipids in ALS, whereas the total amount of lipids compared to proteins is reduced. Our study demonstrates that FTIR characterization of CSF could represent a powerful tool for ALS diagnosis and reveals central features of ALS pathophysiology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du&#x10d;i&#x107;</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2389-3887</Identifier><AffiliationInfo><Affiliation>CELLS-ALBA, Carrer de la Llum 2-26, Cerdanyola del Valles, 08290 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Jan Christoph</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-3778-0683</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medicine G&#xf6;ttingen, Robert-Koch-Str. 40, 37075 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017550" MajorTopicYN="N">Spectroscopy, Fourier Transform Infrared</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017356" MajorTopicYN="N">Synchrotrons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Fourier-transform infrared spectroscopy</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">cerebrospinal fluid</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37296572</ArticleId><ArticleId IdType="pmc">PMC10253168</ArticleId><ArticleId IdType="doi">10.3390/cells12111451</ArticleId><ArticleId IdType="pii">cells12111451</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Suh E., Van Deerlin V.M., Wood E.M., Baek Y., et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Vande Velde C., Cleveland D.W.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., LeClerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.C.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead R.J., Shan N., Reiser H.J., Marshall F., Shaw P.J. Amyotrophic lateral sclerosis: A neurodegenerative disorder poised for successful therapeutic translation. Nat. Rev. Drug Discov. 2022;22:185&#x2013;212. doi: 10.1038/s41573-022-00612-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-022-00612-2</ArticleId><ArticleId IdType="pmc">PMC9768794</ArticleId><ArticleId IdType="pubmed">36543887</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Pradat P.F., Ludolph A.C., Loeffler J.P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N., Shaw P.J. Biomarkers in amyotrophic lateral sclerosis: A review of new developments. Curr. Opin. Neurol. 2020;33:662&#x2013;668. doi: 10.1097/WCO.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000854</ArticleId><ArticleId IdType="pubmed">32796280</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Feneberg E., Weishaupt J., Brettschneider J., Tumani H., Andersen P.M., Arnim C.A.F.V., B&#xf6;hm S., Kassubek J., Kubisch C., et al. Neurofilaments in the diagnosis of motoneuron diseases: A prospective study on 455 patients. J. Neurol. Neurosurg. Psychiatry. 2016;87:12&#x2013;20. doi: 10.1136/jnnp-2015-311387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311387</ArticleId><ArticleId IdType="pubmed">26296871</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreger M., Steinbach R., Otto M., Turner M.R., Grosskreutz J. Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2022;93:422&#x2013;435. doi: 10.1136/jnnp-2021-327503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327503</ArticleId><ArticleId IdType="pmc">PMC8921583</ArticleId><ArticleId IdType="pubmed">35105727</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., De Schaepdryver M., Stubendorff B., Gille B., Muckova P., Wendler S., Prell T., Ringer T.M., Rhode H., Stevens O., et al. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. 2017;88:2302&#x2013;2309. doi: 10.1212/WNL.0000000000004029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004029</ArticleId><ArticleId IdType="pubmed">28500227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.H., Macdonald-Wallis C., Gray E., Pearce N., Petzold A., Norgren N., Giovannoni G., Fratta P., Sidle K., Fish M., et al. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84:2247&#x2013;2257. doi: 10.1212/WNL.0000000000001642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001642</ArticleId><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard S.R., Wuu J., Cardoso M., Wiklendt L., Dinning P.G., Chataway T., Schultz D., Benatar M., Rogers M.L. Urinary p75ECD: A prognostic, disease progression, and pharmacodynamic biomarker in ALS. Neurology. 2017;88:1137&#x2013;1143. doi: 10.1212/WNL.0000000000003741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003741</ArticleId><ArticleId IdType="pmc">PMC5373786</ArticleId><ArticleId IdType="pubmed">28228570</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese A.M., Sharma A., Mishra P., Vijayalakshmi K., Harsha H.C., Sathyaprabha T.N., Bharath S.M.M., Nalini A., Alladi P.A., Raju T.R. Chitotriosidase&#x2014;A putative biomarker for sporadic amyotrophic lateral sclerosis. Clin. Proteom. 2013;10:19. doi: 10.1186/1559-0275-10-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1559-0275-10-19</ArticleId><ArticleId IdType="pmc">PMC4220794</ArticleId><ArticleId IdType="pubmed">24295388</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K., et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Hendrix S., Berry J.D., Elliott M.A., Maiser S., Karam C., Caress J.B., Owegi M.A., Quick A., et al. Trial of Sodium Phenylbutyrate&#x2013;Taurursodiol for Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2020;383:919&#x2013;930. doi: 10.1056/NEJMoa1916945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pmc">PMC9134321</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T., Cudkowicz M., Shaw P.J., Andersen P.M., Atassi N., Bucelli R.C., Genge A., Glass J., Ladha S., Ludolph A.L., et al. Phase 1&#x2013;2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N., Grinberg L.T., Boxer A., Ossenkoppele R., Jonsson M., Seeley W., Ehrenberg A., Spina S., Janelidze S., Rojas-Martinex J., et al. Cerebrospinal fluid biomarkers in autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2022;98:e1137&#x2013;e1150. doi: 10.1212/WNL.0000000000200040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200040</ArticleId><ArticleId IdType="pmc">PMC8935438</ArticleId><ArticleId IdType="pubmed">35173015</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama T., Sawada J., Takahashi K., Yahara O. Cerebrospinal fluid biomarkers in parkinson&#x2019;s disease: A critical overview of the literature and meta-analyses. Brain Sci. 2020;10:466. doi: 10.3390/brainsci10070466.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10070466</ArticleId><ArticleId IdType="pmc">PMC7407121</ArticleId><ArticleId IdType="pubmed">32698474</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Weydt P., Thal D.R., Weishaupt J.H., Ludolph A.C., Otto M. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol. 2020;139:119&#x2013;134. doi: 10.1007/s00401-019-02093-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02093-x</ArticleId><ArticleId IdType="pubmed">31701227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Kee Kwong K.C., Mehta A.R., Nedergaard M., Chandran S. Defining novel functions for cerebrospinal fluid in ALS pathophysiology. Acta Neuropathol. Commun. 2020;8:140. doi: 10.1186/s40478-020-01018-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01018-0</ArticleId><ArticleId IdType="pmc">PMC7439665</ArticleId><ArticleId IdType="pubmed">32819425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Kee Kwong K.C., Gregory J.M., Pal S., Chandran S., Mehta A.R. Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: A systematic review of in vitro studies. Brain Commun. 2020;2:fcaa121. doi: 10.1093/braincomms/fcaa121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa121</ArticleId><ArticleId IdType="pmc">PMC7566327</ArticleId><ArticleId IdType="pubmed">33094283</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M.J., Trevisan J., Bassan P., Bhargava R., Butler H.J., Dorling K.M., Fielden P.R., Fogarty S.W., Fullwood N.J., Heys K.A., et al. Using Fourier transform IR spectroscopy to analyze biological materials. Nat. Protoc. 2014;9:1771&#x2013;1791. doi: 10.1038/nprot.2014.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.110</ArticleId><ArticleId IdType="pmc">PMC4480339</ArticleId><ArticleId IdType="pubmed">24992094</ArticleId></ArticleIdList></Reference><Reference><Citation>Du&#x10d;i&#x107; T., Stamenkovi&#x107; S., Lai B., Andjus P., Lu&#x10d;i&#x107; V. Multimodal Synchrotron Radiation Microscopy of Intact Astrocytes from the hSOD1 G93A Rat Model of Amyotrophic Lateral Sclerosis. Anal. Chem. 2019;91:1460&#x2013;1471. doi: 10.1021/acs.analchem.8b04273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.8b04273</ArticleId><ArticleId IdType="pubmed">30571081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuzer M., Stamenkovi&#x107; S., Chen S., Andjus P., Du&#x10d;i&#x107; T. Lipids status and copper in a single astrocyte of the rat model for amyotrophic lateral sclerosis: Correlative synchrotron-based X-ray and infrared imaging. J. Biophotonics. 2020;13:e202000069. doi: 10.1002/jbio.202000069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.202000069</ArticleId><ArticleId IdType="pubmed">32463554</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer L., G&#xfc;nther R., Koch J.C., Klebe S., Hagenacker T., Lingor P., Biesalski A.S., Hermann A., Nabers A., Gold R., et al. TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2021;8:271&#x2013;277. doi: 10.1002/acn3.51256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51256</ArticleId><ArticleId IdType="pmc">PMC7818221</ArticleId><ArticleId IdType="pubmed">33263951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ami D., Duse A., Mereghetti P., Cozza F., Ambrosio F., Ponzini E., Grandori R., Lunetta C., Tavazzi S., Pezzoli F., et al. Tear-Based Vibrational Spectroscopy Applied to Amyotrophic Lateral Sclerosis. Anal. Chem. 2021;93:16995&#x2013;17002. doi: 10.1021/acs.analchem.1c02546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.1c02546</ArticleId><ArticleId IdType="pmc">PMC8717331</ArticleId><ArticleId IdType="pubmed">34905686</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B., Miller R., Swash M., Munsat T. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. World Federation of Neurology Research Group on Motor Neuron Diseases. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier A., Gaudlitz M., Grehl T., Weyen U., Steinbach R., Gro&#xdf;kreutz J., R&#xf6;diger A., Koch J.C., Lengenfeld T., Weydt P., et al. ALSFRS-R-SE: An adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale. Neurol. Res. Pract. Artic. 2022;4:60. doi: 10.1186/s42466-022-00224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-022-00224-6</ArticleId><ArticleId IdType="pmc">PMC9753252</ArticleId><ArticleId IdType="pubmed">36522775</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dem&#x161;ar J., Curk T., Erjavec A., Gorup &#x10c;., Ho&#x10d;evar T., Milutinovi&#x10d; M., Mo&#x17e;ina M., Polajnar M., Toplak M., Stari&#x10d; A., et al. Orange: Data mining toolbox in python. J. Mach. Learn. Res. 2013;14:2349&#x2013;2353.</Citation></Reference><Reference><Citation>Toplak M., Birarda G., Read S., Sandt C., Rosendahl S.M., Vaccari L., Dem&#x161;ar J., Borondics F. Infrared Orange: Connecting Hyperspectral Data with Machine Learning. Synchrotron Radiat. News. 2017;30:40&#x2013;45. doi: 10.1080/08940886.2017.1338424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08940886.2017.1338424</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek K., Wood B.R., Bambery K.R. Optical Spectroscopy and Computational Methods in Biology and Medicine. Springer Netherlands; Dordrecht, The Netherlands: 2014. FTIR Imaging of Tissues: Techniques and Methods of Analysis; pp. 419&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-007-7832-0_15</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchiatti P., Mitri E., Kenig S., Bille F., Kourousias G., Bedolla D.E., Vaccari L. Contribution of Ribonucleic Acid (RNA) to the fourier transform infrared (FTIR) Spectrum of eukaryotic cells. Anal. Chem. 2016;88:12090&#x2013;12098. doi: 10.1021/acs.analchem.6b02744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.6b02744</ArticleId><ArticleId IdType="pubmed">28193045</ArticleId></ArticleIdList></Reference><Reference><Citation>De Meutter J., Goormaghtigh E. Amino acid side chain contribution to protein FTIR spectra: Impact on secondary structure evaluation. Eur. Biophys. J. 2021;50:641&#x2013;651. doi: 10.1007/s00249-021-01507-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00249-021-01507-7</ArticleId><ArticleId IdType="pmc">PMC8189991</ArticleId><ArticleId IdType="pubmed">33558954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiercigroch E., Szafraniec E., Czamara K., Pacia M.Z., Majzner K., Kochan K., Kaczor A., Baranska M., Malek K. Raman and infrared spectroscopy of carbohydrates: A review. Spectrochim. Acta-Part A Mol. Biomol. Spectrosc. 2017;185 doi: 10.1016/j.saa.2017.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.saa.2017.05.045</ArticleId><ArticleId IdType="pubmed">28599236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly J.G., Najand G.M., Martin F.L. Characterisation of DNA methylation status using spectroscopy (mid-IR versus Raman) with multivariate analysis. J. Biophotonics. 2011;4:345&#x2013;354. doi: 10.1002/jbio.201000085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.201000085</ArticleId><ArticleId IdType="pubmed">21520428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Huang Q., Yan J., Chen Z. Histone Acetylation Induced Transformation of B-DNA to Z-DNA in Cells Probed through FT-IR Spectroscopy. Anal. Chem. 2016;88:4179&#x2013;4182. doi: 10.1021/acs.analchem.6b00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.6b00400</ArticleId><ArticleId IdType="pubmed">27046421</ArticleId></ArticleIdList></Reference><Reference><Citation>Movasaghi Z., Rehman S., ur Rehman D.I. Fourier Transform Infrared (FTIR) Spectroscopy of Biological Tissues. Appl. Spectrosc. Rev. 2008;43:134&#x2013;179. doi: 10.1080/05704920701829043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/05704920701829043</ArticleId></ArticleIdList></Reference><Reference><Citation>Praja R.K., Wongwattanakul M., Tippayawat P., Phoksawat W., Jumnainsong A., Sornkayasit K., Leelayuwat C. Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Discriminates the Elderly with a Low and High Percentage of Pathogenic CD4+ T Cells. Cells. 2022;11:458. doi: 10.3390/cells11030458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11030458</ArticleId><ArticleId IdType="pmc">PMC8834052</ArticleId><ArticleId IdType="pubmed">35159268</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan D.R., Bambery K.R., Heraud P., Tobin M.J., Diem M., McNaughton D., Wood B.R. Monitoring the reversible B to A-like transition of DNA in eukaryotic cells using Fourier transform infrared spectroscopy. Nucleic Acids Res. 2011;39:5439&#x2013;5448. doi: 10.1093/nar/gkr175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr175</ArticleId><ArticleId IdType="pmc">PMC3141270</ArticleId><ArticleId IdType="pubmed">21447564</ArticleId></ArticleIdList></Reference><Reference><Citation>Banyay M., Sarkar M., Gr&#xe4;slund A. A library of IR bands of nucleic acids in solution. Biophys. Chem. 2003;104:477&#x2013;488. doi: 10.1016/S0301-4622(03)00035-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-4622(03)00035-8</ArticleId><ArticleId IdType="pubmed">12878315</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia N.K., Srivastava A., Katyal N., Jain N., Khan M.A.I., Kundu B., Deep S. Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim. Biophys. Acta-Proteins Proteom. 2015;1854:426&#x2013;436. doi: 10.1016/j.bbapap.2015.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2015.01.014</ArticleId><ArticleId IdType="pubmed">25666897</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarroukh R., Cerf E., Derclaye S., Dufr&#xea;ne Y.F., Goormaghtigh E., Ruysschaert J.-M., Raussens V. Transformation of amyloid &#x3b2;(1&#x2013;40) oligomers into fibrils is characterized by a major change in secondary structure. Cell. Mol. Life Sci. 2011;68:1429&#x2013;1438. doi: 10.1007/s00018-010-0529-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-010-0529-x</ArticleId><ArticleId IdType="pubmed">20853129</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauns E.B., Dyer R.B. Time-resolved infrared spectroscopy of RNA folding. Biophys. J. 2005;89:3523&#x2013;3530. doi: 10.1529/biophysj.105.061531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.105.061531</ArticleId><ArticleId IdType="pmc">PMC1366846</ArticleId><ArticleId IdType="pubmed">16126826</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2019;10:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in als and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S., Kuo P.H., Chu L.Y., Golzarroshan B., Jain M., Yuan H.S. RNA recognition motifs of disease-linked RNA-binding proteins contribute to amyloid formation. Sci. Rep. 2019;9:6171. doi: 10.1038/s41598-019-42367-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42367-8</ArticleId><ArticleId IdType="pmc">PMC6467989</ArticleId><ArticleId IdType="pubmed">30992467</ArticleId></ArticleIdList></Reference><Reference><Citation>Andjus P., Stamenkovi&#x107; S., Du&#x10d;i&#x107; T. Synchrotron radiation-based FTIR spectro-microscopy of the brainstem of the hSOD1 G93A rat model of amyotrophic lateral sclerosis. Eur. Biophys. J. 2019;48:475&#x2013;484. doi: 10.1007/s00249-019-01380-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00249-019-01380-5</ArticleId><ArticleId IdType="pubmed">31243482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonar D., Ocek L., Tiftikcioglu B.I., Zorlu Y., Severcan F. Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis. Sci. Rep. 2018;8:1025. doi: 10.1038/s41598-018-19303-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19303-3</ArticleId><ArticleId IdType="pmc">PMC5773569</ArticleId><ArticleId IdType="pubmed">29348591</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Steyn F.J., Ngo S.T., Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: A therapeutic target? Cell Biosci. 2021;11:14. doi: 10.1186/s13578-020-00511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani M., Chi&#xf2; A., Valentini M.C., &#xd6;berg J., Nobili F., Calvo A., Moglia C., Bertuzzo D., Morbelli S., De Carli F., et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology. 2014;83:1067&#x2013;1074. doi: 10.1212/WNL.0000000000000792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000792</ArticleId><ArticleId IdType="pubmed">25122207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiper M.A., Teerlink T., Visser J.J., Bergmans P.L.M., Scheltens P., Wolters E.C. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson&#x2019;s disease, multiple system atrophy, and Alzheimer&#x2019;s disease patients. J. Neural Transm. 2000;107:183&#x2013;189. doi: 10.1007/s007020050016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007020050016</ArticleId><ArticleId IdType="pubmed">10847559</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaitakis A., Constantakakis E., Smith J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann. Neurol. 1988;24:446&#x2013;449. doi: 10.1002/ana.410240314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410240314</ArticleId><ArticleId IdType="pubmed">2906529</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry T.L., Krieger C., Hansen S., Eisen A. Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluid. Ann. Neurol. 1990;28:12&#x2013;17. doi: 10.1002/ana.410280105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410280105</ArticleId><ArticleId IdType="pubmed">2375629</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., Marouan A., Dib M., Meininger V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: A reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J. Neurol. Sci. 2002;193:73&#x2013;78. doi: 10.1016/S0022-510X(01)00661-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00661-X</ArticleId><ArticleId IdType="pubmed">11790386</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I., Janik P. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS) Acta Neurol. Scand. 1999;100:6&#x2013;11. doi: 10.1111/j.1600-0404.1999.tb00717.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb00717.x</ArticleId><ArticleId IdType="pubmed">10416506</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Aniello A., Fisher G., Migliaccio N., Cammisa G., D&#x2019;Aniello E., Spinelli P. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients. Neurosci. Lett. 2005;388:49&#x2013;53. doi: 10.1016/j.neulet.2005.06.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.06.030</ArticleId><ArticleId IdType="pubmed">16039064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat&#xed;as-Guiu J., Gal&#xe1;n L., Garc&#xed;a-Ramos R., Barcia J.A., Guerrero A. Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis. Neurolog&#xed;a. 2010;25:364&#x2013;373. doi: 10.1016/j.nrl.2010.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2010.01.006</ArticleId><ArticleId IdType="pubmed">20738956</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaitakis A., Constantakakis E. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartylglutamate in amyotrophic lateral sclerosis. Brain Res. Bull. 1993;30:381&#x2013;386. doi: 10.1016/0361-9230(93)90269-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(93)90269-H</ArticleId><ArticleId IdType="pubmed">8457887</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I., Janik P., Mickielewicz A., Jamrozik Z., Kwieci&#x144;ski H. Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism. Neurol. Neurochir. Pol. 2001;35:81&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">11732283</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo T., Mancini A., Miroballo M., Casamassa A., Di Maio A., Donati G., Sansone G., Gaetani L., Paoletti F.P., Isidori A., et al. High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer&#x2019;s disease. Amino Acids. 2021;53:435&#x2013;449. doi: 10.1007/s00726-021-02943-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-021-02943-7</ArticleId><ArticleId IdType="pubmed">33616735</ArticleId></ArticleIdList></Reference><Reference><Citation>Joardar A., Manzo E., Zarnescu D.C. Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. Curr. Genet. Med. Rep. 2017;5:108&#x2013;114. doi: 10.1007/s40142-017-0123-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40142-017-0123-8</ArticleId><ArticleId IdType="pmc">PMC5647833</ArticleId><ArticleId IdType="pubmed">29057168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Coccurello R. What is &amp;quot;Hyper&amp;quot; in the ALS Hypermetabolism? Mediat. Inflamm. 2017;2017:7821672. doi: 10.1155/2017/7821672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Lepore E., Martini M., Barberi L., Nunn A., Scicchitano B.M., Musar&#xf2; A. Metabolic Changes Associated With Muscle Expression of SOD1G93A. Front. Physiol. 2018;9:831. doi: 10.3389/fphys.2018.00831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Bonifacino T., Bartolucci M., Milanese M., Gallia E., Provenzano F., Cortese K., Panfoli I., Bonanno G. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2018;55:9220&#x2013;9233. doi: 10.1007/s12035-018-1059-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1059-z</ArticleId><ArticleId IdType="pubmed">29656361</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal I., Lim Y.S., Ng S.-Y., Ling S.-C. Deciphering lipid dysregulation in ALS: From mechanisms to translational medicine. Transl. Neurodegener. 2022;11:48. doi: 10.1186/s40035-022-00322-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00322-0</ArticleId><ArticleId IdType="pmc">PMC9641964</ArticleId><ArticleId IdType="pubmed">36345044</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Prakash P., Wijewardhane P.R., Hasel P., Rufen-Blanchette U., M&#xfc;nch A.E., Blum J.A., Fine J., Neal M.C., et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;599:102&#x2013;107. doi: 10.1038/s41586-021-03960-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03960-y</ArticleId><ArticleId IdType="pubmed">34616039</ArticleId></ArticleIdList></Reference><Reference><Citation>Depciuch J., To&#x142;pa B., Witek P., Szmuc K., Kaznowska E., Osuchowski M., Kr&#xf3;l P., Cebulski J. Raman and FTIR spectroscopy in determining the chemical changes in healthy brain tissues and glioblastoma tumor tissues. Spectrochim. Acta-Part A Mol. Biomol. Spectrosc. 2020;225:117526. doi: 10.1016/j.saa.2019.117526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.saa.2019.117526</ArticleId><ArticleId IdType="pubmed">31655362</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>